Same price every month No price hike Cancel Anytime Based on thousands of happy clients *Results vary by individual
study of over 18,000 patients found tirzepatide users lost approximately 15.3% of body weight at 12 months compared to 8.3% with semaglutide
Tirzepatide was associated with significantly lower risks of major adverse cardiovascular events, all-cause mortality, and all-cause hospitalizations than Semaglutide
Options may include phentermine-topiramate, a combination medication that suppresses appetite, as well as medications originally approved for other conditions, such as the antidepressant bupropion (Wellbutrin) or the diabetes drug metformin
It acts as a supportive topical for better collagen organization and healing, not a solo scar treatment
DOI: 10.1007/s11095-009-0045-6 DailyMed